Picture of Matinas BioPharma Holdings logo

MTNB Matinas BioPharma Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Matinas Biopharma Reports Q1 Loss Per Share Of $0.03

May 10 (Reuters) - Matinas BioPharma Holdings Inc  MTNB.A :
    * MATINAS BIOPHARMA REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
    * Q1 LOSS PER SHARE $0.03
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.03 -- REFINITIV IBES
DATA
    * BELIEVES THAT CASH ON HAND IS SUFFICIENT TO FUND
OPERATIONS INTO
2024.

Source text for Eikon:  ID:nGNX1bQhZH 
Further company coverage:  MTNB.A 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Matinas BioPharma Holdings

See all news